守正弘药
首页
/
体细胞基因编辑肿瘤模型
模型介绍
文献支持
应用案例
/
产品和服务
产品中心
动物模型
常规肿瘤细胞库
单、双基因靶点肿瘤原代细胞库
基因编辑质粒库
动物实验服务
影像检测
行为学实验
细胞实验服务
分子实验服务
病理检测服务
生物信息服务
科研培训服务
/
资源中心
操作视频
技术文章
/
新闻动态
促销活动
新闻动态
/
招商合作
/
关于我们
公司概况
专家团队
联系我们
守正弘药技术团队发表
Bmi1 drives hepatocarcinogenesis by repressing the TGFβ2/SMAD signalling axis
2025-12-17
DOI: 10.1038/s41388-019-1043-8
“Trinity” Comprehensively Regulates the Tumor Microenvironment of Lipid-Coated CaCO3@CuO2 Nanoparticles Induces “Cuproptosis” in HCC
2025-12-17
https://pubs.acs.org/doi/10.1021/acsami.4c10336.
Core-shell cisplatin/SiO2 nanocapsules combined with PTC-209 overcome chemotherapy-Acquired and intrinsic resistance in hepatocellular carcinoma
2025-12-17
DOI: 10.1016/j.actbio.2023.08.021
Metabolic reprogramming in cholangiocarcinoma cancer stem cells: Emerging therapeutic paradigms
2025-12-17
DOI: 10.1016/j.canlet.2025.217714
Bmi1 drives the formation and development of intrahepatic cholangiocarcinoma independent of Ink4A/Arf repression
2025-12-17
https://doi.org/10.1016/j.phrs.2020.105365
Anti-tumor Efficiency of Lipid-coated Cisplatin Nanoparticles Co-loaded
2025-12-17
DOI: 10.7150/thno.13130
β-Catenin signaling in hepatocellular carcinoma
2025-12-17
DOI: 10.1172/JCI154515
Cellular heterogeneity and transcriptomic profiles during intrahepatic cholangiocarcinoma initiation and progression
2025-12-17
DOI: 10.1002/hep.32483
其他研究人员发表
FBP1 controls liver cancer evolution from senescent MASH hepatocytes
2025-12-22
https://doi.org/10.1038/s41586-024-08317-9
FDX1 downregulation activates mitophagy and the PI3K/AKT signaling pathway to promote hepatocellular carcinoma progression by inducing ROS production
2025-12-22
DOI: 10.1016/j.redox.2024.103302
RNA-binding protein CCDC137 activates AKT signaling and promotes hepatocellular carcinoma through a novel non-canonical role of DGCR8 in mRNA localization
2025-12-22
DOI: 10.1186/s13046-023-02749-3
Lysyl oxidase-like 3 restrains mitochondrial ferroptosis to promote liver cancer chemoresistance by stabilizing dihydroorotate dehydrogenase
2025-12-22
DOI: 10.1038/s41467-023-38753-6
AKT (v-akt murine thymoma viral oncogene homolog 1) and N-Ras (neuroblastoma ras viral oncogene homolog) coactivation in the mouse liver promotes rapid carcinogenesis by way of mTOR (mammalian target of rapamycin complex 1), FOXM1 (forkhead box M1)/SKP2, and c-Myc pathways
2025-12-22
DOI: 10.1002/hep.24736
Role of cyclin D1 as a mediator of c-Met- and beta-catenin-induced hepatocarcinogenesis
2025-12-22
DOI: 10.1158/0008-5472.CAN-08-2514
CD36 promotes iron accumulation and dysfunction in CD8+ T cells via the p38-CEBPB-TfR1 axis in early-stage hepatocellular carcinoma
2025-12-22
DOI: 10.3350/cmh.2024.0948
MET promotes hepatocellular carcinoma development through the promotion of TRIB3-mediated FOXO1 degradation
2025-12-22
DOI: 10.3350/cmh.2024.1163
Drives the Growth of Hepatocellular Carcinoma via ANLN and KIF23
2025-12-22
DOI: 10.1053/j.gastro.2023.02.043
High-fat diet promotes liver tumorigenesis via palmitoylation and activation of AKT
2025-12-22
DOI: 10.1136/gutjnl-2023-330826
做动物实验 找守正弘药
技术服务热线
19086384230
联系我们
技术咨询：
19086384230
招商合作：
19086384230
实验基地：
湖北省鄂州市东湖高新智慧城11栋、3期14栋、葛店中小企业创业园
关注我们
咨询实验服务
学习实验操作
